Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Orexo Ab ADR (ORXOY)

Orexo Ab ADR (ORXOY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 13.01
Trade ORXOY with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.4499 unch
on 07/15/21
4.9100 -9.37%
on 06/17/21
-0.4101 (-8.44%)
since 05/14/21
3-Month
4.4499 unch
on 07/15/21
5.4975 -19.06%
on 05/12/21
-0.8696 (-16.35%)
since 04/15/21
52-Week
4.4499 unch
on 07/15/21
6.8500 -35.04%
on 07/17/20
-3.1001 (-41.06%)
since 07/15/20

Most Recent Stories

More News
OTC Markets Group Announces Quarterly Index Performance and Rebalancing

/PRNewswire/ --  (OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the second quarter 2021 performance and quarterly rebalancing of the OTCQX and OTCQB...

VNNHF : 0.6769 (+1.76%)
LGORF : 15.4400 (+2.18%)
NUXFF : 1.1260 (+2.18%)
TUES : 0.2818 (+17.91%)
ABSSF : 28.6500 (-3.41%)
BKRRF : 0.6664 (-0.07%)
BSXGF : 0.4886 (-1.31%)
GPHOF : 0.8350 (+0.60%)
OBTC : 15.9900 (-5.10%)
AKCCF : 2.1200 (+0.95%)
DECPF : 1.5250 (+3.74%)
HRVSF : 3.5000 (-2.23%)
ADDYY : 183.5200 (-0.53%)
CWLPF : 1.7000 (+2.29%)
HCHDF : 2.0200 (-2.42%)
TKGBY : 1.0000 (+3.95%)
WMMVY : 32.8200 (-0.76%)
ZURVY : 40.1400 (-0.12%)
ARBV : 19.0600 (unch)
BSFO : 26.2500 (-0.38%)
CNBB : 43.5000 (+0.46%)
CWBK : 31.0000 (+3.33%)
ESBS : 5.0300 (+0.20%)
GBFH : 10.0000 (unch)
IFHI : 26.7000 (unch)
LUMB : 11.2600 (+0.09%)
LYBC : 42.5500 (-1.05%)
OSBK : 47.0000 (+2.17%)
PBNC : 35.3000 (-1.26%)
TYCB : 36.5000 (unch)
TYFG : 45.9000 (-0.33%)
ABXXF : 2.7800 (-2.80%)
BRCHF : 0.3600 (unch)
CHXMF : 0.6750 (-0.52%)
DMEHF : 3.5400 (-2.34%)
FUNFF : 0.5703 (-3.68%)
ORXOY : 4.4499 (-1.55%)
EMHTF : 0.1450 (unch)
GDNSF : 1.5900 (-4.22%)
TCNNF : 31.4200 (-2.51%)
TNYBF : 0.2149 (-7.33%)
TOBAF : 2.8900 (-2.03%)
VLNCF : 1.9100 (-4.50%)
AURQF : 0.3387 (-0.44%)
BMIX : 0.0110 (-8.33%)
CMPX : 4.5500 (-7.14%)
DGWR : 0.0140 (-7.89%)
HEWA : 0.1900 (-11.63%)
RGRX : 0.2798 (-0.07%)
STVGF : 0.0399 (-33.50%)
OTCM : 44.0000 (-2.22%)
Orexo's flagship pharmaceutical pipeline asset OX124 enters pivotal trial

UPPSALA, Sweden, July 16, 2021 /PRNewswire/ -- Orexo AB (publ.),(STO:ORX) (OTCQX:ORXOY) today announces that the company has successfully initiated the pivotal trial (OX124-002) for its lead pharmaceutical...

ORXOY : 4.4499 (-1.55%)
Orexo Q2 2021 Interim Report

UPPSALA, , /PRNewswire/ -- "First commercial DTx contract signed with a large healthcare provider"

ORXOY : 4.4499 (-1.55%)
Sober Grid Users to Gain Access to Clinically Proven Digital Therapeutics Through New Commercial Partnership with Orexo

/PRNewswire/ -- Sober Grid, the largest social media network for those in addiction recovery, and Orexo, a Swedish pharmaceutical company, today announced that Sober Grid's more than 300,000 users will...

ORXOY : 4.4499 (-1.55%)
Orexo signs commercial partnership agreement with Sober Grid allowing community users access to clinically proven digital therapies vorvida® and deprexis®

UPPSALA, , /PRNewswire/ --Orexo AB (publ.),(STO:ORX) (OTCQX:ORXOY) and Sober Grid, the largest social media network for those in addiction recovery, today announced that Sober Grid's more than 300,000...

ORXOY : 4.4499 (-1.55%)
Orexo announces first patient enrolled in pivotal study evaluating the efficacy of modia(TM) in combination with sublingual buprenorphine/ naloxone for the treatment of OUD

UPPSALA, Sweden, July 1, 2021 /PRNewswire/ -- Orexo AB (publ.),(STO:ORX) (OTCQX:ORXOY), today announces the enrollment of the first participant in the pivotal study of digital therapeutic modia(TM), in...

ORXOY : 4.4499 (-1.55%)
Pain Relief Therapeutics Market 2021 Opportunity Assessment, Business Opportunities, Top Industry Players, Trend and Growth to 2027

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
VRX.TO : 30.80 (-3.33%)
Orexo continues to strengthen ZUBSOLV's patent portfolio with two new patents

UPPSALA, , /PRNewswire/ -- Orexo AB (publ.),(STO:ORX) (OTCQX:ORXOY) today announces that the US Patent and Trademark Office (USPTO) has issued another two patents relating to ZUBSOLV®, Orexo's sublingual...

ORXOY : 4.4499 (-1.55%)
US Pain Relief Therapeutics Market Share 2021 : Growth Opportunities with Covid-19 Impact Analysis, Business Structure with Top Key Players Size, Development Plans and Challenges Forecast to 2027

The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
VRX.TO : 30.80 (-3.33%)
Opioid Use Disorder Market Size 2021 | Is Projected to grow USD 4.81 billion in 2028 at a CAGR of 8.7%

Opioid Use Disorder Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional...

ALKS : 24.14 (-0.94%)
BDSI : 3.64 (+0.55%)
HKMPF : 36.0000 (+0.86%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
TEVA : 8.92 (-0.22%)

Key Turning Points

3rd Resistance Point 4.4499
2nd Resistance Point 4.4499
1st Resistance Point 4.4499
Last Price 4.4499
1st Support Level 4.4499
2nd Support Level 4.4499
3rd Support Level 4.4499

See More

52-Week High 6.8500
Fibonacci 61.8% 5.9332
Fibonacci 50% 5.6500
Fibonacci 38.2% 5.3667
Last Price 4.4499
52-Week Low 4.4499

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar